Immunomodulatory activities of curcumin-stabilized silver nanoparticles: Efficacy as an antiretroviral therapeutic

ABSTRACT We synthesized and characterized curcumin-stabilized silver nanoparticles (Cur-AgNP) and found them to be 45 nm by dynamic light scattering with a maximum absorbance at 406 nm. We evaluated Cur-AgNP for immunomodulatory activities and their potential as an antiretroviral agent. The antiretroviral effects of Cur-AgNP were determined in ACH-2 cells latently infected with human immunodeficiency virus (HIV)-1. ACH-2 cells, 200,000/ml, were treated with Cur-AgNP for 24–48 h. Expression of HIV-1 LTR and p24, the pro-inflammatory cytokines, IL-1β, TNF-α, and NF-κB was quantitated. Treatment of ACH-2 cells latently infected with HIV-1 with Cur-AgNP produced no toxic effects but significantly inhibited the expression of HIV-1 LTR (−73%, P < 0.01) and p24 (−57%, P < 0.05), IL-1βα (−61%, P < 0.01), TNF-αα (−54%, P < 0.05), IL-6 (−68%, P < 0.01), and NF-κB (−79%, P < 0.0001) as compared to untreated controls. Thus, Cur-AgNP have therapeutic potential as direct antiretroviral agents, as well as having immunomodulatory activities inhibiting the expression of pro-inflammatory mediators induced by infection with HIV-1. Experimental controls, such as curcumin alone, and conventional silver nanoparticles capped with citric acid, produced no similar biological effects. We conclude that treatment of HIV-1 infected cells with Cur-AgNP significantly reduced replication of HIV by inhibition of NF-κB nuclear translocation and the downstream expression of the pro-inflammatory cytokines IL-1β, TNF-α, and IL-6. Subsequent in vivo studies with Cur-AgNP using a humanized mouse model of HIV infection are underway.

[1]  M. Rosini,et al.  Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea , 2018, Molecules.

[2]  O. Çiftçi,et al.  Curcumin protects heart tissue against irinotecan-induced damage in terms of cytokine level alterations, oxidative stress, and histological damage in rats , 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  D. Bachvarov,et al.  Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment. , 2017, Journal of agricultural and food chemistry.

[4]  Amjad Ali,et al.  Curcumin inhibits HIV-1 by promoting Tat protein degradation , 2016, Scientific Reports.

[5]  C. Huang,et al.  Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. , 2016, Nanoscale.

[6]  S. Polyak,et al.  Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic Infection , 2015, Viruses.

[7]  S. Prasad,et al.  Curcumin and its analogues: a potential natural compound against HIV infection and AIDS. , 2015, Food & function.

[8]  Tatiana Ammosova,et al.  Inhibition of HIV-1 by curcumin A, a novel curcumin analog , 2015, Drug design, development and therapy.

[9]  S. Thorgeirsson,et al.  Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. , 2015, Journal of hepatology.

[10]  Zhimei Song,et al.  Linolenic acid-modified PEG-PCL micelles for curcumin delivery. , 2014, International journal of pharmaceutics.

[11]  Ying Tan,et al.  Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage , 2014, Inflammation Research.

[12]  Jian-hai Chen,et al.  Preparation of novel curcumin-loaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy. , 2014, International journal of pharmaceutics.

[13]  A. Ingle,et al.  Metal nanoparticles: The protective nanoshield against virus infection , 2014, Critical reviews in microbiology.

[14]  Wim E Hennink,et al.  Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. , 2014, Biomaterials.

[15]  H. J. Um,et al.  Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[16]  G. J. Gabriel,et al.  Facile synthesis of silver nanoparticles stabilized by cationic polynorbornenes and their catalytic activity in 4-nitrophenol reduction. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[17]  S. Shyue,et al.  Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. , 2012, Molecular nutrition & food research.

[18]  J. Snyder,et al.  Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. , 2012, International immunopharmacology.

[19]  Elsa N. Garza Treviño,et al.  Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins , 2011, Journal of nanobiotechnology.

[20]  Raju C Reddy,et al.  Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro , 2011, PloS one.

[21]  H. H. Lara,et al.  Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds , 2011, Journal of nanobiotechnology.

[22]  R. Sharma,et al.  Metal nanoparticles with high catalytic activity in degradation of methyl orange: An electron relay effect , 2011 .

[23]  Murali M. Yallapu,et al.  Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. , 2010, Macromolecular bioscience.

[24]  H. Maibach,et al.  Nanofibrous materials for wound care , 2010, Cutaneous and ocular toxicology.

[25]  R. Das,et al.  Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[26]  C. Rodríguez-Padilla,et al.  Mode of antiviral action of silver nanoparticles against HIV-1 , 2010, Journal of nanobiotechnology.

[27]  M. Diederich,et al.  Effect of Curcumin on Nuclear Factor κB Signaling Pathways in Human Chronic Myelogenous K562 Leukemia Cells , 2009 .

[28]  A. Mathur,et al.  Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Fabrication and Characterization of Silk Fibroin-derived Curcumin Nanoparticles for Cancer Therapy , 2022 .

[29]  E. Srivatsan,et al.  Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor κB by an AKT-Independent Pathway , 2008, Clinical Cancer Research.

[30]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[31]  A. Mobasheri,et al.  Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. , 2007, Biochemical pharmacology.

[32]  P. Mukherjee,et al.  Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. , 2007, International journal of pharmaceutics.

[33]  D. Haller,et al.  Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. , 2006, The Journal of nutrition.

[34]  Jie Yin,et al.  A simple method for selective immobilization of silver nanoparticles , 2005 .

[35]  E. Manheimer,et al.  Herbal medicines for treating HIV infection and AIDS. , 2005, The Cochrane database of systematic reviews.

[36]  M. Yacamán,et al.  Interaction of silver nanoparticles with HIV-1 , 2005, Journal of nanobiotechnology.

[37]  A. Gopalan,et al.  Preparation of catalytically efficient precious metallic colloids by γ-irradiation and characterization , 2005 .

[38]  Tania Nolan,et al.  Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. , 2004, Journal of biomolecular techniques : JBT.

[39]  Y. Shon,et al.  Aqueous synthesis of alkanethiolate-protected Ag nanoparticles using Bunte salts. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[40]  Surendra S. Ambegaokar,et al.  Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. , 2003, Neuro endocrinology letters.

[41]  M. Tsuji,et al.  Laser induced morphology change of silver colloids: formation of nano-size wires , 2003 .

[42]  N. Sobal,et al.  Preparation of silver nanoparticles by interphase reduction , 1999 .

[43]  B. Aggarwal,et al.  Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.

[44]  B. Aggarwal,et al.  The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*) , 1995, The Journal of Biological Chemistry.

[45]  A. Fauci,et al.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Zhong Zheng,et al.  Current development of silver nanoparticle preparation, investigation, and application in the field of medicine , 2015 .

[47]  A. Tiwari,et al.  APPLICATION OF SILVER NANOPARTICLES IN VIRAL INHIBITION: A NEW HOPE FOR ANTIVIRALS , 2014 .

[48]  R. Rajaram,et al.  Curcumin conjugated gold nanoparticle synthesis and its biocompatibility , 2014 .

[49]  R. Rajaram,et al.  Investigations on the interaction of gold-curcumin nanoparticles with human peripheral blood lymphocytes. , 2011, Journal of biomedical nanotechnology.

[50]  T. Horie,et al.  Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. , 1999, Pharmacological research.

[51]  B. Aggarwal,et al.  Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. , 1995, The Journal of biological chemistry.